<DOC>
	<DOC>NCT02985684</DOC>
	<brief_summary>Evaluate the safety and efficacy of the GORE® CARDIOFORM ASD Occluder in the percutaneous closure of ostium secundum atrial septal defects (ASDs)</brief_summary>
	<brief_title>Safety and Efficacy Study of Transcatheter Closure of Ostium Secundum ASDs</brief_title>
	<detailed_description>This is a prospective, multicenter, single-arm clinical study comparing outcomes with the GORE® CARDIOFORM ASD Occluder to performance goals derived from clinical investigation outcomes for devices indicated for ASD closure.</detailed_description>
	<mesh_term>Heart Septal Defects</mesh_term>
	<mesh_term>Heart Septal Defects, Atrial</mesh_term>
	<criteria>Appropriate ASD anatomy Note: Additional Inclusion Criteria may apply Absence of concurrent cardiac conditions that could elevate morbidity/mortality beyond what is common for ASD Note: Additional Exclusion Criteria may apply</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>